Exodus Point Capital Management, LP Compugen LTD Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.09 - $7.16 $104,941 - $183,711	-25,658 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $88,194 - $121,952	15,206 Added 145.48%	25,658 $153,000
Q2 2021 Aug 16, 2021	BUY	$6.87 - $9.16 $71,805 - $95,740	10,452 New	10,452 $87,000
Q1 2021 May 17, 2021	SELL	$7.67 - $13.77 $166,845 - $299,538	-21,753 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $477,839 - $710,622	-39,589 Reduced 64.54%	21,753 $263,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $868,602 - $1.19 Million	61,342 New	61,342 $997,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.